As CAFs represent a relevant component of the tumor microenvironment implicated in complex biological responses such as angiogenesis, cell migration, invasion, inflammation, and immune evasion, our data provide novel evidence on the opportunity to control aberrant microenvironmental responses conducive to BC progression by means of RAGE targeting. This evidence concerns the gene AGER and neoplasm.